Physician samples not subject to duty as per court ruling The appeal was allowed based on the decision referenced, and the demand for duty on physician samples was not upheld. The judgment was pronounced in court ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Physician samples not subject to duty as per court ruling
The appeal was allowed based on the decision referenced, and the demand for duty on physician samples was not upheld. The judgment was pronounced in court on 21/06/2018. The case clarified that physician samples are liable to be charged Central Excise duty based on MRP, but certain clearances may not fall under this valuation method. The assessment for physician samples sold was to be done under Section 4(1)(a), while for samples manufactured on a job-work basis, the assessment was to be done in accordance with the decisions of the Apex court in the case of Ujjagar Prints.
Issues: Confirmation of demand of duty on physician samples based on MRP valuation method; Applicability of extended period of limitation; Different valuation methods for physician samples sold and manufactured on job-work basis.
Analysis: The appeal was filed against the confirmation of duty demand on physician samples. The appellant discharged duty on a cost construction basis, while the Revenue sought to demand duty based on MRP. The appellant argued that the issue was disputable within the industry and referred to a circular by CBE&C. The Tribunal had previously upheld different views on this matter. However, based on a decision of the High Court, it was held that physician samples are liable to be charged Central Excise duty based on MRP. The appellant further argued that MRP valuation should not apply to certain clearances based on various decisions cited.
The learned AR relied on the impugned order, but the Tribunal found that the issue was covered by a previous decision in the case of Sun Pharmaceuticals. The Tribunal emphasized that the price was charged by the assessee from the distributors, and the transaction between them was relevant for valuation. Therefore, the case fell under Section 4(1)(a) of the Act, and the demand based on MRP was not sustainable. The assessment for physician samples sold was to be done under Section 4(1)(a), while for samples manufactured on a job-work basis, the assessment was to be done in accordance with the decisions of the Apex court in the case of Ujjagar Prints.
Ultimately, the appeal was allowed based on the decision referenced, and the demand for duty on physician samples was not upheld. The judgment was pronounced in court on 21/06/2018.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.